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Transposon-generated ‘knock-out’ and ‘knock-in’ 
gene-targeting constructs for use in mice
Christoph Heiner Westphal and Philip Leder
The conventional technique for targeted mutation of
mouse genes entails placing a genomic DNA fragment
containing the gene of interest into a vector for fine
mapping, followed by cloning of two genomic arms
around a selectable neomycin-resistance cassette in a
vector containing thymidine kinase [1]; this generally
requires 1–2 months of work for each construct. The
single ‘knock-out’ construct is then transfected into
mouse embryonic stem (ES) cells, which are
subsequently subjected to positive selection (using
G418 to select for neomycin-resistance) and negative
selection (using FIAU to exclude cells lacking thymidine
kinase), allowing the selection of cells which have
undergone homologous recombination with the knock-
out vector. This approach leads to inactivation of the
gene of interest [2]. Recently, an in vitro reaction was
developed, on the basis of the yeast Ty transposon, as
a useful technique in shotgun sequencing [3]. An
artificial transposable element, integrase enzyme and
the target plasmid are incubated together to engender
transposition. The DNA is then purified, and
subsequently electroporated into bacteria. The
transposon and the target plasmid bear distinct
antibiotic resistance markers (trimethoprim and
ampicillin, respectively), allowing double selection for
transposition events. In the present study, we have
modified this system to allow the rapid, simultaneous
generation of a palette of potential gene targeting
constructs. Our approach led from genomic clone to
completed construct ready for transfection in a matter
of days. The results presented here indicate that this
technique should also be applicable to the generation
of gene fusion constructs [4–8], simplifying this
technically demanding method
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Results and discussion
In our transposon-based approach, a genomic fragment
containing exon sequences of interest is cloned into a
vector containing a number of unique enzyme sites and the
thymidine kinase gene (TK) at the edge of the multiple
cloning site (see Figure 1). As a first step (Figure 1a),
enzyme sites at the edge of a genomic clone of interest are
destroyed (in the case illustrated here, a genomic SpeI frag-
ment is cloned into an XbaI site). In the second step
(Figure 1b), a simple transposition reaction leads to the
random integration of the transposon into the genomic
clone. The transposon bears sequences recognized by a
number of rare cutters at its extremities, some of which are
indicated in Figure 1b. Thousands of unique, individual
transposition events can be recovered as distinct doubly
resistant colonies from a typical reaction ([3] and our
unpublished observations). The desired events — transpo-
sitions into the exon of interest — are discerned via a
screen that relies on the polymerase chain reaction (PCR)
applied to bacterial colonies, using oligonucleotides homol-
ogous to the exon DNA. Ligation of a neomycin-resistance
(neo) cassette into the unique transposon enzyme sites
completes the generation of the gene-targeting construct.
Neomycin resistance facilitates the selection of homolo-
gous recombination events on the basis of regaining exter-
nal enzyme sites (Figure 1c), and recombinants are verified
by Southern blot analysis. Only those constructs undergo-
ing homologous recombination will regain the original
enzyme sites at the edge of the construct, at defined dis-
tances from the probe. The desired homologous recombi-
nants can then be independently verified by an external
probe, if desired. Figure 1d illustrates the vector, named
CWKO, that was used for this study, with all the unique
sites listed. A genomic fragment containing enzyme sites
listed in parentheses will, when cloned into the cognate
unique site in this vector, destroy those sites in the
genomic DNA. Enzymes that are convenient for lineariza-
tion of the completed construct are boxed.
In the present study, we chose to target the mouse neuro-
endocrine 7B2 gene, the product of which interacts with
the prohormone convertase PC2 protein [9]. The 7B2
gene is located within 50 kilobases (kb) of the 3′ end of
the formin gene (our unpublished observations and [10]).
A 7.5 kb genomic SpeI fragment was isolated from a bacte-
rial artificial chromosome and cloned into an XbaI site in
the CWKO vector. A simple transposition reaction, entail-
ing incubation and subsequent phenol extraction steps,
was then performed (see Materials and methods section).
Colony PCR using oligonucleotides homologous to exon
DNA indicated that 4 of 288 transposition events were
marked by integration into the exon of interest. Figure 2a
shows a representative panel of colony PCR products,
with the endogenous 150 bp exon band present when
integration has taken place elsewhere in the genomic
clone. An ‘up-shift’ to 1.1 kb occurs when the transposon
has inserted into exonic DNA, labeled here as 2–53 and
2–70 (note that the transposon is roughly 900 bp).
Sequence data, presented in Figure 2b, confirm that trans-
position has indeed taken place into the 7B2 exon 3. We
have confirmed that this approach is generally applicable
by generating transpositions into exonic DNA of two other
genomic fragments which were used for gene targeting
constructs (data not shown). Note that multiple constructs
of different genes can be produced simultaneously using
this procedure, as a number of transposition reactions may
be performed in parallel (Perkin Elmer/ABI routinely
perform six or more reactions simultaneously; C. Andre,
personal communication).
As a final step, we transfected the knock-out vector gener-
ated in the present study into ES cells, as described previ-
ously [11]. Linearization of plasmids for transfection into
ES cells was achieved with a hypercleavable site for
PiSceI, which has a 36 bp recognition site [12] and has no
reported sites within the mouse genome. We obtained 63
resistant ES clones, of which two were proven to have
undergone homologous recombination (Figure 3). Figure
3b shows that ES clones 50 and 59 have the predicted 5 kb
band when using a transposon probe (P1 in Figure 3a),
whereas ES clone 36 has no detectable band, and ES
clone 22 has a band at 4 kb. Figure 3c is a genomic South-
ern using exon DNA from the mouse 7B2 gene as a probe.
This probe is not truly internal, since one is looking to
regain two SpeI sites, external to the gene-targeting con-
struct, at defined distances. It would be extraordinarily
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Figure 1
Transposon-mediated generation of mouse ‘knock-out’ and ‘knock-in’
vectors. (a) Cloning of a representative SpeI genomic clone containing
two exons (Ex) into an XbaI site of the targeting vector, destroying the
genomic SpeI sites. (b) In an in vitro transposition reaction, the
transposon inserts randomly into the targeting vector. Each
ampicillin/trimethoprim-resistant colony represents a unique
transposition event. The transposon carries sequences for rare-cutting
enzymes at both edges, into which the neo cassette is inserted by
sticky-end ligation. (c) Homologous recombination between the
targeting vector and genomic DNA, such that the external SpeI sites
are regained, allowing the design of a diagnostic genomic Southern
blot (see Figure 3 for details). (d) A map of the targeting vector
CWKO (not drawn to scale). All unique enzyme sites convenient for
cloning are indicated. Cognate genomic sites, which can be cloned
into the unique vector sites destroying the genomic sites, are indicated
in parentheses. Unique enzyme sites useful for targeting vector
linearization are boxed. The vector contains the thymidine kinase and
ampicillin resistance (bla) genes.
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Figure 2
Bacterial colony PCR demonstrates the insertion of the transposon
into exon DNA, as verified by sequencing the transposition junction. As
described in the text, a genomic SpeI clone containing exonic
sequences of the mouse neuroendocrine 7B2 gene was cloned into
the targeting vector CWKO. An in vitro transposition reaction was
performed, and resultant ampicillin/trimethoprim-resistant colonies
were screened using oligonucleotides capable of amplifying 150 bp of
exonic sequences. (a) Two of the four clones demonstrated an
expected up-shift to 1.1 kb (2–53 and 2–70), indicating that the
transposon had inserted within exon 3 of the mouse 7B2 gene. (b) The
sequence of the transposition site, which was subsequently used to
complete the targeting vector. Convenient SacII and NotI sites of the
transposon, juxtaposed with exon sequences of the 7B2 gene, are
labeled.
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unlikely to obtain an insertional event which regained rel-
atively rare-cutting enzyme sites at precisely the same
location on both sides of the construct. Since the neo cas-
sette contains one SpeI site (see Figure 3a), the predicted
alteration in the genomic locus is a down-shift from 7.5 kb
to a doublet at 5.0 kb and 4.9 kb on genomic SpeI digest,
which is seen in ES clones 50 and 59 in Figure 3c (note
that the neo cassette and transposon make the final tar-
geted locus 9.9 kb). This observation is confirmed in
Figure 3d, which shows a corresponding up-shift from
6 kb to 7.6 kb upon genomic BamHI digest, using an alter-
nate probe. Note that both knock-out (7.6 kb) and
endogenous (6 kb) bands are of equal intensity, indicating
that the endogenous locus has been targeted. 
The results presented here are based largely on statistical
reasoning. We hope that a simple example will illustrate
that, given sufficient numbers of random integration events,
a number of desired integrants will almost certainly be iso-
lated using this method. Assuming that a given genomic
clone is 7.5 kb and contains 375 bp of exonic sequences
(genomic DNA is thought to contain roughly 5% exonic
sequences), then the chance of one random integration not
occurring in the exonic DNA for this example will be the
length of all non-exonic vector DNA divided by the length
of total DNA, to the first power. Expressed mathematically,
this is ((7.5 kb + 2.5 kb – 0.375 kb) / (7.5 kb + 2.5 kb))1, or
(9,625/10,000)1, since the transposon may also insert in
2.5 kb of the knock-out vector which are not taken up by
the ampicillin-resistance cassette. The chance of 100
random integrations not occurring in the exon DNA will,
by extension, be (9,625/10,000)100 = 2%. In our laboratory,
300 colony PCR reactions can be set up in under 2 hours,
and the likelihood of not recovering a desired insert would
then become (9,625/10,000)300 = 0.001%. Note that we
and others have routinely obtained thousands of transposi-
tional events per reaction, so that the limiting factor is
essentially the number of colony PCR reactions one
chooses to perform.
The transposon-mediated approach described here may
be generally applicable for the generation of insertional
knock-out vectors. The technique is rapid, leading from
genomic clone to finished construct in a minimum of four
days, and a number of constructs may be generated simul-
taneously. In addition, different exons in the same
genomic clone may be targeted. This can prove useful
when different truncations may shed light on the func-
tional significance of distinct protein domains. Finally, the
generation of ‘knock-in’ mice, traditionally an arduous
task — in which a portion of the wild-type gene is fused to
the cDNA of a heterologous gene — is greatly simplified
by the random integration of transposons bearing rare-
cutting enzyme sequences. Hence, cloning any cDNA of
interest in-frame into a specific genomic locus becomes
much less challenging and time-consuming than previ-
ously. Several recent papers have indicated the power of
such knock-in technology in analyses of the functional
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Homologous recombination is verified by genomic SpeI and BamHI
digests. (a) Homologous recombination leads to regaining of genomic
SpeI sites (originally destroyed in the targeting vector by cloning into
an XbaI site; see Figure 1). Genomic SpeI and BamHI sites are
indicated, as is a SpeI site within the neo cassette. Transposon DNA
(P1) and exonic DNA (P2) were used as probes. As indicated by the
sequence shown in Figure 2b, the transposon inserted just after the
eightieth base-pair of the 7B2 exon 3. A unique NotI site in the
transposon was used to clone in the PGK-neoc bpA cassette. (b) The
transposon probe identifies a 5 kb band in ES clones 50 and 59, but
no band in ES clone 36 and a 4 kb band in ES clone 22. (c) The
expected 5.0 kb and 4.9 kb doublet on SpeI digestion of DNA from
clones 50 and 59. All other ES clones showed different banding
patterns, represented by that seen in two nontargeted clones, 36 and
22. (d) Upon BamHI digestion, clones 50 and 59 show the expected
up-shift from the endogenous 6 kb to 7.6 kb, with both bands being of
equal intensity. In contrast, all other ES clones showed different
banding patterns, and the alternate bands were never of equal intensity
(the patterns seen in ES clones 36 and 22 are shown).
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complementation between related genes [4], the use of
lacZ fusion proteins for precise developmental expression
studies [5,13], and the modeling of human cancer translo-
cations [6–8]. We believe that this technique is especially
applicable to these types of biological questions, and are
currently working on such approaches.
Materials and methods
Construction of the knock-out vector, CWKO
The Invitrogen pSL301 Superlinker plasmid was modified in the follow-
ing manner. HindIII and NotI sites were filled in using Klenow poly-
merase. A 36 bp hypercleavable recognition site for PiSceI (also
containing a HindIII site) was inserted between EcoRI and SalI sites.
Oligonucleotide ligation created AscI and PmeI sites between the SalI
and HindIII sites. The thymidine kinase gene, isolated from the knock-
out vector pPNT [1], was blunt-end ligated into a unique MscI site. Diag-
nostic digestion verified each unique enzyme site listed in Figure 1d.
Generation of transposition events
The manufacturer’s protocol (ABI, Perkin Elmer) was followed exactly.
Briefly, 200 ng of transposon, 1 mg of target plasmid, integrase, buffer,
and water were incubated at 30°C for 1 h. The reaction was stopped
with 0.25 M EDTA, 1% SDS, and 5 mg ml–1 proteinase K at 65°C for
15 min. After phenol extraction, the product was precipitated with
ammonium acetate and isopropanol, washed in 70% ethanol, and
resuspended in 10 ml of water; 1 ml was electroporated into highly
competent bacterial cells, and plated on selective medium containing
75 mg ml–1 ampicillin and trimethoprim. A typical reaction yielded
100–300 colonies per ml, or 1,000–3,000 colonies total. These
colonies became apparent on agarose plates 12–15 h after transfor-
mation. The only requirements for the transposable element are a 4 bp
repeat at either end of a linear, double-stranded DNA molecule
[14,15]; random integration into the target DNA engenders only a 5 bp
duplication at the site of insertion. Once the transposable element has
integrated into the target DNA, it becomes transposition-incompetent. 
Colony PCR
Single bacterial colonies were dipped into a master mix containing
0.4 mM primers, 0.2 mM dNTP, 1× PCR buffer, Taq polymerase, and
water. The primers used were 5′-AGTTTTCCCAAGAGGACAGG-3′
and 5′-TTCTTCCCACGCTGCAGGG-3′, which amplify exon 3 of the
mouse 7b2 gene [16]. Samples were heated to 94°C for 5 min, and
then subjected to 30 cycles of 45 sec 94°C, 30 sec 55°C, and 1 min
72°C. After dipping into the PCR master mix, colonies were touched to
a master plate, which was incubated at 37°C while PCR and gel analy-
sis was performed. After completion of the PCR reaction in 2.5 h, 1.5%
agarose gels were loaded with a multichannel pipettor and run out with
markers, to discern the desired transposition events. Setting up 300
PCR reactions, running the PCR program, and loading and analyzing
gels was completed in 6–8 h, and colonies from the master plate were
then picked and grown up in miniprep format for 8 h. Sticky-end liga-
tion of PGK-neoc bpA into the targeted exon and subsequent sequenc-
ing of the construct was completed in 2 days. Completed constructs
were sequenced using a standard protocol (ABI, Perkin Elmer) and
analyzed on an ABI 377 automated sequencer.
Homologous recombination in ES cells
ES cell transfection and culture were performed as described previ-
ously [11]. Briefly, 40 mg linearized targeting vector was electroporated
into ES cells and subjected to positive (G418) and negative (FIAU)
selection. Resistant clones were isolated and grown up for DNA, for
subsequent analysis by genomic Southern blot.
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